ML070680292

Fitness-For-Duty Program Semiannual Performance Report

ML070680292
Person / Time
Site:	Palo Verde
Issue date:	02/28/2007
From:	Bauer S Arizona Public Service Co
To:	Document Control Desk, Office of Nuclear Reactor Regulation
References
102-05650-SAB/TNW/CJJ
Download: ML070680292 (7)

Text

10 CFR 26.71(d) mA A subsidiary of PinnacleWest Capital Corporation Scott A. Bauer Mail Station 7636 Palo Verde Nuclear Department Leader Tel. 623-393-5978 PO Box 52034 Generating Station Regulatory Affairs Fax 623-393-5442 Phoenix, Arizona 85072-2034 102-05650-SAB/TNW/CJJ February 28, 2007 Document Control Desk U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

Subject:

Palo Verde Nuclear Generating Station (PVNGS)

Units 1, 2 and 3 Docket Nos. STN 50-52815291530 Fitness-For-Duty Program Semiannual Performance Report Pursuant to 10 CFR 26.71(d), Arizona Public Service Company hereby provides, as an enclosure to this letter, the Fitness-For-Duty Program Semiannual Performance Report for the reporting period of July 1, 2006 through December 31, 2006.

No commitments are being made to the NRC by this letter. Should you have any questions, please contact Thomas N. Weber at (623) 393-5764.

Sincerely, SAB/TNW/CJJ/gt Enclosure cc: B. S. Mallett NRC Region IV Regional Administrator M.T. Markley NRC NRR Project Manager G. G. Warnick NRC Senior Resident Inspector for PVNGS A member of the STARS (Strategic Teaming and Resource Sharing) Alliance A ,D.z-j Callaway

• Comanche Peak

• Diablo Canyon

• Palo Verde 9 South Texas Project

• Wolf Creek

ENCLOSURE 1 SEMIANNUAL PERFORMANCE REPORT July 1, 2006 through December 31, 2006

Introduction The Arizona Public Service Company (APS) Fitness-for-Duty (FFD) Program continues to remain successful in its mission to maintain a drug-free workplace. During this reporting period, APS conducted 2059 tests. Of these, 730 were administered on a random basis. An equivalent annual testing rate of 52.3 percent was achieved during this reporting period.

APS experienced four confirmed positive random drug and alcohol tests during this reporting period. Therefore, the percentage of confirmed positive random drug and alcohol tests for this period is 0.54 percent.

Analysis of Program Results The confirmed positive drug and alcohol test results for this reporting period by type of test and type of drug are summarized in Table 1 and 2 respectively and are discussed below.

Pre-Access Testing:

Marijuana 3 Alcohol 1 Total 4 confirmed positive tests Comments: APS tested a total of 1045 individuals under the Pre-Access Testing category during this reporting period. Four individuals tested positive. Three of the individuals were contractors. Site access was denied and the individuals were released to their employers. One individual was an APS employee. The individual completed a mandatory treatment program and was placed in the follow-up program.

For Cause Testing:

Marijuana 2 Amphetamines 2 Alcohol 1 Cocaine 3 Total: 8 Confirmed Positive Tests Comments: APS tested a total of 77 individuals under the For Cause testing category during this reporting period. For cause testing includes; behavior observation, post accident, suspected adulteration of specimens, or an odor of alcohol on an individual. Seven individuals tested positive. One individual tested positive for two drugs, marijuana and amphetamines. Four of the individuals testing positive were contractors. Site access was denied and the individuals were released to their employers. Three of the individuals testing positive were APS employees. Two of the individuals were denied site access and terminated. This included the individual testing positive for two drugs. The terminations were not based solely on the results of the drug/alcohol test. The third APS individual completed a mandatory treatment program and was placed in the follow-up program.

Random Testing:

Marijuana 3 Amphetamine 1 Total 4 Confirmed Positive Tests Comments: APS conducted a total of 730 tests under the Random category during this reporting period. Four individuals tested positive. The four individuals were contractors. Site access was denied and the individuals were released to their employer.

Follow-up Testing:

Total 0 Confirmed Positive Tests Comments: APS conducted a total of 88 tests under the Follow-up category during this reporting period. None of the individuals tested were positive.

Other:

Total 0 Confmned Positive Tests Comments: APS tested 119 individuals in the other testing category during this reporting period.

This category includes pre-employment testing. None of the individuals tested were positive.

Reportable Events:

There were no reportable events during this reporting period.

Fitness for Duty Program Performance Data Personnel Subject to 10 CFR 26 December 31, 2006 Arizona Public Service Company Company 6 months ending Palo Verde Nuclear Generating Station (PVNGS)

Location Ouida Bland (623) 393-3228 Contact Name Phone(include area code)

Cutoffs: Screen/Confirmation (ng/ml) Appendix A to 10 CFR 26 Marijuana 100/15 Amphetamines 1000/500 Cocaine 300/150 Phencyclidine 25/25 Opiates 300/300 Alcohol (% BAC) 0.04%

PVNGS screening test for Marijuana uses a cut off level of 50 ng/ml Long-Term Short-Term Testing Results Licensee Contractor Contractor Employees Personnel Personnel Average Number with 2070 NA 721 Unescorted Access Categories Tested Positive Tested Positive Tested Positive Pre- Access 223 1 NA NA 822 3 For Post accident 14 1 NA NA 17 0 Cause Observed behavior 22 2 NA NA 24 4 Random 576 0 NA NA 154 4 Follow-Up 55 0 NA NA 33 0 Other 119 0 NA NA 0 0 Total 1009 4 NA NA 1050 11

Breakdown of Confirmed Positive Tests for Specific Substances Ampheta Phency- Refusal Marijuana Cocaine Opiates mines cildine Alcohol to Test Total Licensee Employees 1 2 0 1 0 1 0 5 Long-Term Contractors NA NA NA NA NA NA NA NA Short-Term Contractors 7 1 0 2 0 1 0 11 Total 8 3 0 3 0 2 0 16 Additional Information Required by 10 CFR 26.71 (d)

Specimens screening positive for marijuana at 50 ng/ml: 10 Specimens screening positive for marijuana at 100 ng/ml: 7 These numbers include blind specimens sent to offsite lab for testing.